Development of an orthotopic model of human metastatic prostate cancer in the NOD‑SCIDγ mouse (Mus musculus) anterior prostate
Author
dc.contributor.author
Cifuentes, Federico F.
Author
dc.contributor.author
Valenzuela, Rodrigo H.
Author
dc.contributor.author
Contreras, Héctor R.
Author
dc.contributor.author
Castellón, Enrique A.
Admission date
dc.date.accessioned
2015-12-15T13:43:39Z
Available date
dc.date.available
2015-12-15T13:43:39Z
Publication date
dc.date.issued
2015
Cita de ítem
dc.identifier.citation
Oncology Letters
Volumen: 10 Número: 4 oct 2015
en_US
Identifier
dc.identifier.other
doi: 10.3892/ol.2015.3522
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/135726
General note
dc.description
Artículo de publicación ISI
en_US
Abstract
dc.description.abstract
Prostate cancer is one of the most prevalent oncological diseases in males worldwide, and the mortalities resulting from this type of cancer are mainly due to metastasis. The most common models for the study of metastasis are transgenic and immunocompromised mice, which enable the study of the metastatic process in a controlled way by the injection of prostate cancer cells into the mice. In the present study, NOD‑SCIDγ mice were injected orthotopically with PC3 cells in the anterior prostate in order to establish a metastatic model. The results demonstrated the development and growth of a primary tumor that preceded the formation of micrometastases in the lung, liver and pancreas, followed by macrometastases in the liver. This model adequately represents the dynamics of the metastatic process, and may be useful for novel therapeutic assays and post-surgical relapse studies.